Cargando…
The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness
Bladder cancer is a highly prevalent disease worldwide and is associated with a high mortality rate. Across all stages of bladder cancer, immunotherapy has now become the cornerstone of treatment. The commensal microbiome has become a major focus of research given its impact on numerous states of hu...
Autores principales: | Andolfi, Ciro, Bloodworth, Jeffrey C., Papachristos, Apostolos, Sweis, Randy F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605348/ https://www.ncbi.nlm.nih.gov/pubmed/33195783 http://dx.doi.org/10.3233/BLC-200277 |
Ejemplares similares
-
The Urinary Microbiome and Bladder Cancer
por: Heidar, Nassib Abou, et al.
Publicado: (2023) -
A validated mathematical model of FGFR3-mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer
por: Okuneye, Kamaldeen, et al.
Publicado: (2021) -
The Urinary Microbiome: Role in Bladder Cancer and Treatment
por: Friedrich, Veronika, et al.
Publicado: (2022) -
Urinary Microbiome in Bladder Diseases—Review
por: Chorbińska, Joanna, et al.
Publicado: (2023) -
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
por: Kacew, Alec, et al.
Publicado: (2020)